{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:35:53Z","timestamp":1787495753257,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["03ZU1111LB"],"award-info":[{"award-number":["03ZU1111LB"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["01KT2304B"],"award-info":[{"award-number":["01KT2304B"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["SE2980\/5-1"],"award-info":[{"award-number":["SE2980\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kroner-Fresenius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"German Cancer Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005960","name":"Deutsches Rote Kreuz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005960","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004038","name":"Jung Foundation for Science and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.isci.2025.113871","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:32:56Z","timestamp":1761647576000},"page":"113871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Soluble TIM-3 and galectin-9 predict survival in gastric and gastroesophageal junction cancer"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2139-9183","authenticated-orcid":false,"given":"David","family":"Digomann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6449-8335","authenticated-orcid":false,"given":"Charlotte","family":"Reiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1280-967X","authenticated-orcid":false,"given":"Antonia","family":"Stammberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7084-863X","authenticated-orcid":false,"given":"Tido","family":"Willms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9096-2139","authenticated-orcid":false,"given":"Loreen S.","family":"Rudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Grabenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Klimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5137-6122","authenticated-orcid":false,"given":"Jamie","family":"K\u00f6lbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2540-6421","authenticated-orcid":false,"given":"Felix","family":"Merboth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2144-552X","authenticated-orcid":false,"given":"Loreen","family":"Natusch Bufe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4379-7406","authenticated-orcid":false,"given":"Carolin","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0343-8301","authenticated-orcid":false,"given":"Ther\u00e9s","family":"Golle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2794-4917","authenticated-orcid":false,"given":"Sarah","family":"Cronjaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4382-7950","authenticated-orcid":false,"given":"Franziska","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2779-4750","authenticated-orcid":false,"given":"Luisa","family":"Kranich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3417-6736","authenticated-orcid":false,"given":"Marc","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6590-8181","authenticated-orcid":false,"given":"Christiane J.","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1304-7719","authenticated-orcid":false,"given":"Hans A.","family":"Schl\u00f6\u00dfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4763-8127","authenticated-orcid":false,"given":"Lena","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5329-3164","authenticated-orcid":false,"given":"Adrian M.","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.113871_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2503701","article-title":"Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer","volume":"393","author":"Janjigian","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.113871_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10501","article-title":"Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints","volume":"7","author":"Koyama","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.113871_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2025.113871_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.113871_bib5","article-title":"TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression","volume":"7","author":"Gao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113871_bib6","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood-2011-11-392951","article-title":"Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity","volume":"119","author":"Ndhlovu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.isci.2025.113871_bib7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-06231-0","article-title":"B-cell-specific checkpoint molecules that regulate anti-tumour immunity","volume":"619","author":"Bod","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.113871_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1126\/science.1148536","article-title":"Promotion of Tissue Inflammation by the Immune Receptor Tim-3 Expressed on Innate Immune Cells","volume":"318","author":"Anderson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.113871_bib9","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1084\/jem.20150388","article-title":"Tim-3 enhances Fc\u03b5RI-proximal signaling to modulate mast cell activation","volume":"212","author":"Phong","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2025.113871_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni988","article-title":"Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance","volume":"4","author":"Sabatos","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.113871_bib11","doi-asserted-by":"crossref","first-page":"34529","DOI":"10.1074\/jbc.M113.488478","article-title":"A Disintegrin and Metalloprotease (ADAM) 10 and ADAM17 Are Major Sheddases of T Cell Immunoglobulin and Mucin Domain 3 (Tim-3)","volume":"288","author":"M\u00f6ller-Hackbarth","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.113871_bib12","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm.2871","article-title":"Bat3 promotes T cell responses and autoimmunity by repressing Tim-3\u2013mediated cell death and exhaustion","volume":"18","author":"Rangachari","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.113871_bib13","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1073\/pnas.1712107115","article-title":"Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion","volume":"115","author":"Avery","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.113871_bib14","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2025.113871_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh2169","article-title":"A single\u2013cell type transcriptomics map of human tissues","volume":"7","author":"Karlsson","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.isci.2025.113871_bib16","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1038\/s41388-020-1186-7","article-title":"Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels","volume":"39","author":"Seifert","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2025.113871_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2018.02.022","article-title":"Unconventional secretion of annexins and galectins","volume":"83","author":"Popa","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.isci.2025.113871_bib18","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S1462399408000719","article-title":"Galectins: structure, function and therapeutic potential","volume":"10","author":"Yang","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.isci.2025.113871_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijsu.2018.06.033","article-title":"Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis","volume":"56","author":"Long","year":"2018","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.isci.2025.113871_bib20","first-page":"2115","article-title":"Association between Tim-3 and Gal-9 expression and gastric cancer prognosis","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.isci.2025.113871_bib21","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.113871_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41416-021-01607-3","article-title":"TIM3+ cells in gastric cancer: clinical correlates and association with immune context","volume":"126","author":"Chen","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2025.113871_bib23","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.3390\/ijms20112634","article-title":"Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model","volume":"20","author":"Chiyo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.113871_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081799","article-title":"Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.113871_bib25","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2025.113871_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: A population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.isci.2025.113871_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1470-2045(22)00704-5","article-title":"Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries","volume":"24","author":"Soerjomataram","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2025.113871_bib28","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2025.113871_bib29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/cancers15030664","article-title":"A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When?","volume":"15","author":"Januszewicz","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2025.113871_bib30","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/gutjnl-2024-332705","article-title":"Where are we with gastric cancer screening in Europe in 2024?","volume":"73","author":"Leja","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.isci.2025.113871_bib31","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/jama.2014.10498","article-title":"Prevention of gastric cancer","volume":"312","author":"Herrero","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2025.113871_bib32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41416-020-0901-z","article-title":"Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer","volume":"123","author":"Lin","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2025.113871_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115445","article-title":"Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases","volume":"209","author":"Bailly","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2025.113871_bib34","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.7150\/thno.71833","article-title":"Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2025.113871_bib35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2025.113871_bib36","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","article-title":"Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Kang","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2025.113871_bib37","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1200\/JCO.23.01601","article-title":"First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial","volume":"42","author":"Janjigian","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.113871_bib38","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1926762","article-title":"Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients","volume":"10","author":"Machiraju","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.isci.2025.113871_bib39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40425-018-0449-0","article-title":"Soluble immune checkpoints in cancer: production, function and biological significance","volume":"6","author":"Gu","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2025.113871_bib40","article-title":"Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance","volume":"5","author":"Chen","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.113871_bib41","first-page":"9452","article-title":"Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis","volume":"8","author":"Cheng","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.isci.2025.113871_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47235-z","article-title":"Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels","volume":"9","author":"Sideras","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.113871_bib43","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3390\/jcm12072636","article-title":"Updated Immunotherapy for Gastric Cancer","volume":"12","author":"Narita","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.isci.2025.113871_bib44","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.gendis.2022.05.020","article-title":"A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)","volume":"10","author":"Lv","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.isci.2025.113871_bib45","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1038\/s41467-022-32627-z","article-title":"scRNA-seq of gastric tumor shows complex intercellular interaction with an alternative T cell exhaustion trajectory","volume":"13","author":"Sun","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.113871_bib46","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.isci.2025.113871_bib47","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ncponc0252","article-title":"Reporting recommendations for tumor MARKer prognostic studies (REMARK)","volume":"2","author":"McShane","year":"2005","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.113871_bib48","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.113871_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2025.113871_bib50","doi-asserted-by":"crossref","first-page":"979","DOI":"10.12688\/f1000research.73600.1","article-title":"Doublet identification in single-cell sequencing data using scDblFinder","volume":"10","author":"Germain","year":"2021","journal-title":"F1000Res."},{"key":"10.1016\/j.isci.2025.113871_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202249923","article-title":"Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods","volume":"53","author":"Bayerl","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.isci.2025.113871_bib52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2025.113871_bib53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41698-023-00459-9","article-title":"Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer","volume":"7","author":"Digomann","year":"2023","journal-title":"Precis. Onc"},{"key":"10.1016\/j.isci.2025.113871_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: Nonparametric Preprocessing for Parametric Causal Inference","volume":"42","author":"Ho","year":"2011","journal-title":"J. Stat. Softw."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225021327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225021327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:51:55Z","timestamp":1782867115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225021327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2589004225021327"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.113871","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble TIM-3 and galectin-9 predict survival in gastric and gastroesophageal junction cancer","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.113871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113871"}}